AstraZeneca
AZN
#42
Rank
S$387.89 B
Marketcap
S$250.21
Share price
2.90%
Change (1 day)
27.29%
Change (1 year)

AstraZeneca (AZN) - Total debt

Total debt on the balance sheet as of December 2025 : S$37.61 Billion

According to AstraZeneca's latest financial reports the company's total debt is S$37.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AstraZeneca - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31S$37.42 B-8.57%
2024-12-31S$40.93 B9.1%
2023-12-31S$37.51 B-3.97%
2022-12-31S$39.06 B-5.83%
2021-12-31S$41.48 B53.88%
2020-12-31S$26.96 B9.72%
2019-12-31S$24.57 B-5.89%
2018-12-31S$26.11 B9.63%
2017-12-31S$23.81 B-2.09%
2016-12-31S$24.32 B14.25%
2015-12-31S$21.29 B48.62%
2014-12-31S$14.32 B8.98%
2013-12-31S$13.14 B4.27%
2012-12-31S$12.60 B4.37%
2011-12-31S$12.08 B1.69%
2010-12-31S$11.87 B-23.52%
2009-12-31S$15.53 B850.99%
2008-12-31S$1.63 B-92.51%
2007-12-31S$21.80 B1062.96%
2006-12-31S$1.87 B-6.22%
2005-12-31S$1.99 B-3.41%
2004-12-31S$2.07 B167.8%
2003-12-31S$0.77 B-47.21%
2002-12-31S$1.46 B-17.25%
2001-12-31S$1.76 B20.79%
2000-12-31S$1.46 B-21.36%
1999-12-31S$1.86 B-0.84%
1998-12-31S$1.87 B-4.92%
1997-12-31S$1.97 B13.57%
1996-12-31S$1.73 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$61.85 B 64.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$45.65 B 21.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$82.54 B 119.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$17.88 B-52.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$54.85 B 45.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$30.81 B-18.07%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$8.48 B-77.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$63.67 B 69.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$60.83 B 61.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$30.79 B-18.13%๐Ÿ‡ฌ๐Ÿ‡ง UK